Switch to ADA Accessible Theme
Close Menu

More Than 20 Plaintiffs Accusing Tylenol Of Liver Disease

A group of more than 20 plaintiffs are accusing Tylenol of causing liver damage, and asking a judge to consolidate their cases into a federal multidistrict litigation.

The 25 plaintiffs, who are represented by a law firm in Philadelphia, say there are 28 cases of liver disease from acetaminophen-containing Tylenol products, and all argue the common questions of fact of whether the products are defective and failed to properly warn users of the risk of liver toxicity.

The group of plaintiffs includes 21 individuals from Pennsylvania, along with eight others from Mississippi, California, New York, Florida, New Jersey and Massachusetts. The location of the multidistrict litigation will be in Pennsylvania, as a division of McNeil, PPC, the makers of Tylenol, is located in the state.

A judicial panel will decide whether the litigation will be approved.

Drug maker McNeil was the first to market acetaminophen products in the United States in 1955, and has advertised for over 35 years as the ‘most trusted pain-reliever that doctors recommend most.’

Earlier this month, some CVS stores have stopped carrying Tylenol products, due to years of manufacturing problems and recalls by McNeil. About half of CVS stores will continue to stock Tylenol. In 2009, Tylenol had 56.

Prescription and over-the-counter medications are intended to improve your quality of life and even sustain life; they are used by millions of people worldwide. The Food and Drug Administration (FDA) is the governmental agency that oversees drug manufacturers and serves as a gatekeeper to introducing new drugs to U.S. patients. The FDA may approve a drug or device it believes to be safe, only to add warnings of potential serious side effects or completely recall the drug or device at a later time.

For more information, contact us.

Source: Daily Business Review, “More than 20 Tylenol plaintiffs seeking multidistrict litigation,” Jan. 23, 2013.

Facebook Twitter LinkedIn